Kevin Read has a background in drug metabolism and pharmacokinetics, with extensive experience in early phase drug discovery, lead optimization, project leadership and preclinical development gained from more than 30 years in the pharmaceutical industry and with the Drug Discovery Unit at the University of Dundee (DDU). His passion is to drive lead optimization forward, working closely with the medicinal chemists to deliver high quality candidate molecules for entry into formal preclinical development. Since moving to Dundee in 2008, Dr. Read has established a drug metabolism and pharmacokinetics (DMPK) unit and pulled together a team of DMPK scientists with extensive Biopharma DMPK experience. Dr. Read possesses expertise in CNS drug discovery gained from over 15 years’ experience in CNS drug discovery lead optimization teams whilst at GlaxoSmithKline.